EXAMINE THIS REPORT ON KETAMINE THERAPY

Most clinical research accept the job of drugs modulating by NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is apparent at minimal doses, and with increasing doses, it mimics psychotomimetic action and inevitably contributes to anesthesia in increased doses.[4]Unexpected emerge